97 related articles for article (PubMed ID: 8616829)
21. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
22. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
23. Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines.
Touitou I; Vignon F; Cavailles V; Rochefort H
J Steroid Biochem Mol Biol; 1991; 40(1-3):231-7. PubMed ID: 1958526
[TBL] [Abstract][Full Text] [Related]
24. Modulation of cathepsin-D and pS2 protein levels in human breast cancer cell lines.
Cappelletti V; Fioravanti L; Miodini P; Di Fronzo G
Tumour Biol; 1996; 17(5):290-8. PubMed ID: 8792855
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
Murphy CS; Pink JJ; Jordan VC
Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
[TBL] [Abstract][Full Text] [Related]
26. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase.
El-Zarruk AA; van den Berg HW
Cancer Lett; 1999 Aug; 142(2):185-93. PubMed ID: 10463775
[TBL] [Abstract][Full Text] [Related]
27. In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer.
Maudelonde T; Escot C; Pujol P; Rouanet P; Defrenne A; Brouillet JP; Rochefort H
Eur J Cancer; 1994; 30A(14):2049-53. PubMed ID: 7857701
[TBL] [Abstract][Full Text] [Related]
28. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.
Daly RJ; Darbre PD
Cancer Res; 1990 Sep; 50(18):5868-75. PubMed ID: 2393857
[TBL] [Abstract][Full Text] [Related]
29. Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth.
Touitou I; Mathieu M; Rochefort H
Biochem Biophys Res Commun; 1990 May; 169(1):109-15. PubMed ID: 2350335
[TBL] [Abstract][Full Text] [Related]
30. Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells.
Krishnan V; Narasimhan T; Safe S
Anal Biochem; 1992 Jul; 204(1):137-42. PubMed ID: 1381155
[TBL] [Abstract][Full Text] [Related]
31. Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?
Dabrosin C; Johansson AC; Ollinger K
Breast Cancer Res Treat; 2004 Jun; 85(3):229-38. PubMed ID: 15111761
[TBL] [Abstract][Full Text] [Related]
32. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades.
Marsigliante S; Muscella A; Ciardo V; Barker S; Leo G; Baker V; Mottaghi A; Vinson GP; Storelli C
Cancer Lett; 1993 Dec; 75(3):195-206. PubMed ID: 7906196
[TBL] [Abstract][Full Text] [Related]
33. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
Bazzett LB; Watkins CS; Gercel-Taylor C; Taylor DD
Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
[TBL] [Abstract][Full Text] [Related]
34. Induction of cathepsin D protein during estrogen carcinogenesis: possible role in estrogen-mediated kidney tubular cell damage.
Li SA; Liao DZ; Yazlovitskaya EM; Pantazis CG; Li JJ
Carcinogenesis; 1997 Jul; 18(7):1375-80. PubMed ID: 9230283
[TBL] [Abstract][Full Text] [Related]
35. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
Rajah TT; Dunn ST; Pento JT
Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
[TBL] [Abstract][Full Text] [Related]
36. 17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin.
Poutanen M; Moncharmont B; Vihko R
Cancer Res; 1992 Jan; 52(2):290-4. PubMed ID: 1728403
[TBL] [Abstract][Full Text] [Related]
37. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.
Castronovo V; Taraboletti G; Liotta LA; Sobel ME
J Natl Cancer Inst; 1989 May; 81(10):781-8. PubMed ID: 2523976
[TBL] [Abstract][Full Text] [Related]
38. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.
Oursler MJ; Pederson L; Fitzpatrick L; Riggs BL; Spelsberg T
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5227-31. PubMed ID: 8202473
[TBL] [Abstract][Full Text] [Related]
39. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells.
Touitou I; Cavaillès V; Garcia M; Defrenne A; Rochefort H
Mol Cell Endocrinol; 1989 Oct; 66(2):231-8. PubMed ID: 2612733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]